• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Artificial intelligence-enabled opportunistic identification of immune checkpoint inhibitor-related adverse events using [F]FDG PET/CT.

作者信息

Spielvogel Clemens P, Lazarevic Aleksa, Zisser Lucia, Haberl David, Eseroglou Christophoros, Beer Lucian, Hacker Marcus, Calabretta Raffaella

机构信息

Division of Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Spitalgasse 23, Vienna, A-1090, Austria.

Division of General and Pediatric Radiology, Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.

出版信息

Eur J Nucl Med Mol Imaging. 2025 May 29. doi: 10.1007/s00259-025-07364-2.

DOI:10.1007/s00259-025-07364-2
PMID:40439712
Abstract
摘要

相似文献

1
Artificial intelligence-enabled opportunistic identification of immune checkpoint inhibitor-related adverse events using [F]FDG PET/CT.使用[F]FDG PET/CT通过人工智能实现免疫检查点抑制剂相关不良事件的机会性识别。
Eur J Nucl Med Mol Imaging. 2025 May 29. doi: 10.1007/s00259-025-07364-2.
2
Organ-specific accuracy of [F]FDG-PET/CT in identifying immune-related adverse events in patients with high-risk melanoma treated with adjuvant immune checkpoint inhibitor.[F]FDG-PET/CT 对高危黑色素瘤患者接受辅助免疫检查点抑制剂治疗后免疫相关不良事件的器官特异性诊断准确性。
Jpn J Radiol. 2024 Jul;42(7):753-764. doi: 10.1007/s11604-024-01554-y. Epub 2024 Mar 20.
3
Interpretation of 2-[F]FDG PET/CT in Hodgkin lymphoma patients treated with immune checkpoint inhibitors.免疫检查点抑制剂治疗霍奇金淋巴瘤患者的 2-[F]FDG PET/CT 解读。
Eur Radiol. 2022 Sep;32(9):6536-6544. doi: 10.1007/s00330-022-08669-8. Epub 2022 Mar 28.
4
Immune Checkpoint Inhibitor-Related Adverse Effects and F-FDG PET/CT Findings.免疫检查点抑制剂相关不良反应及 F-FDG PET/CT 表现。
J Nucl Med Technol. 2021 Dec;49(4):324-329. doi: 10.2967/jnmt.121.262151. Epub 2021 Jul 30.
5
Role of quantitative imaging biomarkers in an early FDG-PET/CT for detection of immune-related adverse events in melanoma patients: a prospective study.定量成像生物标志物在早期 FDG-PET/CT 检测黑色素瘤患者免疫相关不良事件中的作用：一项前瞻性研究。
Radiol Oncol. 2024 Sep 15;58(3):335-347. doi: 10.2478/raon-2024-0045. eCollection 2024 Sep 1.
6
F-FDG-PET/CT Uptake by Noncancerous Lung as a Predictor of Interstitial Lung Disease Induced by Immune Checkpoint Inhibitors.非癌性肺组织对F-FDG-PET/CT的摄取作为免疫检查点抑制剂诱导的间质性肺疾病的预测指标
Acad Radiol. 2025 Feb;32(2):1026-1035. doi: 10.1016/j.acra.2024.08.043. Epub 2024 Sep 2.
7
Early-time-point F-FDG-PET/CT and other prognostic biomarkers of survival in metastatic melanoma patients receiving immunotherapy.接受免疫治疗的转移性黑色素瘤患者的早期F-FDG-PET/CT及其他生存预后生物标志物
Radiol Oncol. 2025 Feb 27;59(1):43-53. doi: 10.2478/raon-2025-0014. eCollection 2025 Mar 1.
8
Is F-FDG-PET/CT an Optimal Imaging Modality for Detecting Immune-Related Adverse Events after Immune-Checkpoint Inhibitor Therapy? Pros and Cons.F-FDG-PET/CT是检测免疫检查点抑制剂治疗后免疫相关不良事件的最佳成像方式吗？利弊分析。
Cancers (Basel). 2024 May 24;16(11):1990. doi: 10.3390/cancers16111990.
9
Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot study.免疫检查点阻断治疗转移性黑色素瘤患者免疫相关不良反应的定量成像生物标志物：一项初步研究。
Eur J Nucl Med Mol Imaging. 2022 May;49(6):1857-1869. doi: 10.1007/s00259-021-05650-3. Epub 2021 Dec 27.
10
F-FDG PET and CT Scans Detect New Imaging Patterns of Response and Progression in Patients with Hodgkin Lymphoma Treated by Anti-Programmed Death 1 Immune Checkpoint Inhibitor.氟代脱氧葡萄糖正电子发射断层扫描和计算机断层扫描检测抗程序性死亡 1 免疫检查点抑制剂治疗的霍奇金淋巴瘤患者新的反应和进展成像模式。
J Nucl Med. 2018 Jan;59(1):15-24. doi: 10.2967/jnumed.117.193011. Epub 2017 Jun 8.

引用本文的文献

1
Endocrine Adverse Events Induced by Cancer Treatments: The Role of F-Fluorodeoxyglucose Positron Emission Tomography.癌症治疗引起的内分泌不良事件：F-氟脱氧葡萄糖正电子发射断层扫描的作用
Cancers (Basel). 2025 Aug 14;17(16):2651. doi: 10.3390/cancers17162651.
2
Synthetic imaging for research and education in nuclear medicine: Who's afraid of the black box?核医学研究与教育中的合成成像：谁害怕黑匣子？
Eur J Nucl Med Mol Imaging. 2025 Mar 22. doi: 10.1007/s00259-025-07214-1.

本文引用的文献

1
Automatic Segmentation of Cardiovascular Structures on Chest CT Data Sets: An Update of the TotalSegmentator.胸部CT数据集中心血管结构的自动分割：TotalSegmentator的更新
Eur J Radiol. 2025 Apr;185:112006. doi: 10.1016/j.ejrad.2025.112006. Epub 2025 Feb 15.
2
Using artificial intelligence to switch from accident to sagacity in the serendipitous detection of uncommon diseases.利用人工智能在偶然发现罕见疾病时从偶然转向睿智。
Lancet Digit Health. 2025 Feb;7(2):e104-e105. doi: 10.1016/j.landig.2024.12.006.
3
EANM/SNMMI guideline/procedure standard for [F]FDG hybrid PET use in infection and inflammation in adults v2.0.
欧洲核医学协会/美国核医学与分子影像学会关于成人感染与炎症中[F]FDG 混合正电子发射断层显像应用的指南/程序标准 v2.0
Eur J Nucl Med Mol Imaging. 2025 Jan;52(2):510-538. doi: 10.1007/s00259-024-06915-3. Epub 2024 Oct 10.
4
Quantitative evaluation of lesion response heterogeneity for superior prognostication of clinical outcome.定量评估病变反应异质性以更好地预测临床结局。
Eur J Nucl Med Mol Imaging. 2024 Oct;51(12):3505-3517. doi: 10.1007/s00259-024-06764-0. Epub 2024 May 31.
5
TotalSegmentator: Robust Segmentation of 104 Anatomic Structures in CT Images.全段分割器：CT图像中104种解剖结构的稳健分割
Radiol Artif Intell. 2023 Jul 5;5(5):e230024. doi: 10.1148/ryai.230024. eCollection 2023 Sep.
6
Opportunistic Screening: Scientific Expert Panel.机会性筛查：科学专家组
Radiology. 2023 Jun;307(5):e222044. doi: 10.1148/radiol.222044. Epub 2023 May 23.
7
Five-year survival and clinical correlates among patients with advanced non-small cell lung cancer, melanoma and renal cell carcinoma treated with immune check-point inhibitors in Australian tertiary oncology centres.在澳大利亚三级肿瘤中心接受免疫检查点抑制剂治疗的晚期非小细胞肺癌、黑色素瘤和肾细胞癌患者的 5 年生存率和临床相关性。
Cancer Med. 2023 Mar;12(6):6788-6801. doi: 10.1002/cam4.5468. Epub 2022 Nov 20.
8
F-FDG PET/CT features of immune-related adverse events and pitfalls following immunotherapy.免疫治疗相关不良反应的 F-FDG PET/CT 特征及注意事项。
J Med Imaging Radiat Oncol. 2022 Jun;66(4):483-494. doi: 10.1111/1754-9485.13390. Epub 2022 Feb 22.
9
Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in the Large Arteries of Lymphoma Patients under 50 Years of Age.免疫检查点抑制剂疗法在50岁以下淋巴瘤患者的大动脉中诱导炎症活动。
Biology (Basel). 2021 Nov 19;10(11):1206. doi: 10.3390/biology10111206.
10
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update.免疫检查点抑制剂治疗患者免疫相关不良反应的管理：ASCO 指南更新。
J Clin Oncol. 2021 Dec 20;39(36):4073-4126. doi: 10.1200/JCO.21.01440. Epub 2021 Nov 1.